In HCC cells, miR-375 suppresses tumor progression by directly targeting HMGA2, thereby inhibiting cell proliferation, glycolysis, and tumor growth, while promoting apoptosis (Xu et al., 2021). Here, HMGA2 is linked to neoplasm.